AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cardinal Health Trading Volume Surges 60.2% to $343 Million Ranking 282nd
Generated by AI AgentAinvest Volume Radar
Tuesday, Jun 10, 2025 8:20 pm ET1min read
On June 10, 2025,
(CAH) saw a significant increase in trading volume, with a turnover of $343 million, marking a 60.2% rise from the previous day. This surge placed Cardinal Health at the 282nd position in terms of trading volume for the day. However, the stock price experienced a slight decline, falling by 0.35% over the past two days, resulting in a total decrease of 1.05%.BofA Securities analyst Michael Cherny raised the price target for Cardinal Health shares to $170.00, up from the previous $165.00. This adjustment comes ahead of the company's upcoming investor day on June 12, where expectations are high due to the company's impressive execution over the past two years and multiple industry tailwinds. The firm anticipates that Cardinal Health will raise its long-term target Pharmaceutical EBIT growth guidance from 4-6% to 5-7% or 5-8%.
TD Cowen also maintained a Buy rating on Cardinal Health stock, reiterating the positive outlook ahead of the company's Investor Day. The firm's price target for Cardinal Health was also increased to $170.00, reflecting the company's strong performance and industry tailwinds.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Abivax Surges 20.69% on Eli Lilly Takeover Hints and Nasdaq Index Inclusion Ranks 166th in Market Activity
Dec.22 2025
Agnico Eagle Surges 3.4% Despite 167th-Ranked $0.55B Volume Driven by Strong Earnings and Institutional Bullishness
Dec.22 2025
FedEx Stock Climbs 1.39% Amid 57.62% Drop in Trading Volume Ranks 132nd in Market Activity
Dec.22 2025
Progressive Gains 1.37% Amid 144th-Ranked Volume as Institutional Jitters and Earnings Miss Cloud Outlook
Dec.22 2025
Airbnb Stock Rises 1.23% Amid 54.5% Volume Plunge Ranks 141st in Market Activity
Dec.22 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet